Insider Transactions in Q1 2021 at Nex Immune, Inc. (NEXI)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2021
|
John Trainer Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,432
+6.67%
|
$17,160
$5.17 P/Share
|
|
Feb 17
2021
|
Sol J Barer |
BUY
Conversion of derivative security
|
Indirect |
1,695,583
+25.46%
|
-
|
|
Feb 17
2021
|
Sol J Barer |
BUY
Open market or private purchase
|
Indirect |
60,000
+3.75%
|
$1,020,000
$17.0 P/Share
|
|
Feb 17
2021
|
Sol J Barer |
BUY
Conversion of derivative security
|
Direct |
800,182
+36.91%
|
-
|
|
Feb 17
2021
|
Timothy Bertram |
BUY
Conversion of derivative security
|
Direct |
71,749
+26.12%
|
-
|
|
Feb 17
2021
|
Scott Carmer President and CEO |
BUY
Conversion of derivative security
|
Direct |
7,058
+50.0%
|
-
|
|
Feb 17
2021
|
Paul D'Angio |
BUY
Conversion of derivative security
|
Direct |
27,847
+25.87%
|
-
|
|
Feb 17
2021
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
175,000
+19.67%
|
$2,975,000
$17.0 P/Share
|
|
Feb 17
2021
|
Grant Verstandig |
BUY
Conversion of derivative security
|
Direct |
539,895
+50.0%
|
-
|
|
Feb 17
2021
|
Alan S. Roemer Director |
BUY
Conversion of derivative security
|
Direct |
127,984
+20.46%
|
-
|
|
Feb 17
2021
|
Jerome B Zeldis Executive VP of Research & Dev |
BUY
Open market or private purchase
|
Direct |
5,882
+50.0%
|
$99,994
$17.0 P/Share
|
|
Feb 17
2021
|
Kristi Jones President and CEO |
BUY
Open market or private purchase
|
Direct |
911
+1.42%
|
$15,487
$17.0 P/Share
|
|
Feb 17
2021
|
Kristi Jones President and CEO |
BUY
Conversion of derivative security
|
Direct |
14,738
+19.16%
|
-
|